4-Oxo-1-propyl-1,4-dihydropyrido[1,2-a]pyrrolo[2,3-d]pyrimidine-2-carboxylic acid, 97%, 100mg

Cycloastragenol, ��98.0%, 5g

1,3,2-Dioxaborolane, 2-[2-[(3,4-dichlorophenyl)methoxy]phenyl]-4,4,5,5-tetramethyl-, 95%, 5g

N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-O-trityl-L-homoserine, 97%, 5g

1-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1,3-DIOXOISOINDOLIN-4-YL)AMINO)-3,6,9,12,15,18-HEXAOXAHENICOSAN-21-OIC ACID, 95%, 250mg

(3H-Imidazo[4,5-b]pyridin-5-yl)methanol, 95.0%, 5g

2-(tert-Butoxycarbonyl)-2-azabicyclo[2.1.1]hexane-5-carboxylic acid, 95%, 250mg

5-(Trifluoromethyl)-2,3-dihydro-1H-inden-1-amine hydrochloride, 95.0%, 100mg

1,1'-(3-(Methoxy(phenyl)methylene)-2-oxoindoline-1,6-diyl)bis(ethan-1-one), 98%, 100mg

2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethanol, 95.0%, 5g

N,2,6-trimethylaniline, 100mg

(R)-2,2-dimethyl-1,3-dioxolane-4-carbaldehyde(50% in Chlorocyclohexane), 95%, 100mg

5,7-Dimethyl[1,8]naphthyridin-2-amine, 95%, 5g